Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA Fact Sheet  (BPHR)



For You: Midcap Stocks Research at Less than Its Launch Price


Here is the latest financial fact sheet of BAL PHARMA. For more details, see the BAL PHARMA quarterly results and BAL PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

BAL PHARMA Price History

Price Rs 99.3
Mkt Cap Rs m 1,570
Vol '000 1.9
P/E X 44.4
P/CF X 13.4
EPS (TTM) Rs 2.2
1 Day % -0.1
No. of shares m 15.81
1 Week % -4.3
1 Month % 5.0
1 Year % 39.9
52 week H/L Rs 132.2/70.0
As on Apr 16, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BAL PHARMA Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
BAL PHARMA EQUITY SHARE DATA
High Rs1097973149134 
Low Rs6324295363 
Sales per share (Unadj.) Rs158.8120.7169.0189.8193.9 
Earnings per share (Unadj.) Rs1.5-9.13.23.81.7 
Diluted earnings per shareRs1.4-8.23.03.61.7 
Cash flow per share (Unadj.) Rs5.9-3.79.69.97.5 
Dividends per share (Unadj.) Rs1.0001.001.001.00 
Adj. dividends per shareRs0.900.000.940.940.99 
Avg Dividend yield %1.202.01.01.0 
Book value per share (Unadj.) Rs47.037.035.538.940.7 
Adj. book value per shareRs42.233.233.336.540.4 
Shares outstanding (eoy) m14.1714.1714.8214.8215.69 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x0.50.40.30.50.5 
Avg P/E ratio x56.5-5.616.026.259.2 
P/CF ratio (eoy) x14.6-13.95.310.113.2 
Price / Book Value ratio x1.81.41.42.62.4 
Dividend payout %65.8031.526.059.9 
Avg Mkt Cap Rs m1,2177277531,4941,549 
No. of employees `000NANANANANA 
Total wages/salary Rs m503504419473553 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
BAL PHARMA INCOME DATA
Net Sales Rs m2,2501,7112,5052,8123,042 
Other income Rs m101911529 
Total revenues Rs m2,2601,7292,5172,8643,052 
Gross profit Rs m17750246240253 
Depreciation Rs m6277959091 
Interest Rs m127127122109123 
Profit before tax Rs m-2-135419247 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-24-6-63521 
Profit after tax Rs m22-129475726 
Gross profit margin %7.92.99.88.58.3 
Effective tax rate %1,166.04.7-14.937.944.8 
Net profit margin %1.0-7.51.92.00.9 
BAL PHARMA BALANCE SHEET DATA
Current assets Rs m1,8301,5741,6411,8462,282 
Current liabilities Rs m1,6321,5951,5251,6562,093 
Net working cap to sales %8.8-1.24.66.76.2 
Current ratio x1.11.01.11.11.1 
Inventory Days Days7151198 
Debtors Days Days1,0491,0589799781,128 
Net fixed assets Rs m783810759760829 
Share capital Rs m142142148148157 
"Free" reserves Rs m525383378429481 
Net worth Rs m666524526577638 
Long term debt Rs m288231239270305 
Total assets Rs m2,6132,3842,4012,6053,110 
Interest coverage x1.0-0.11.31.81.4 
Debt to equity ratio x0.40.40.50.50.5 
Sales to assets ratio x0.90.71.01.11.0 
Return on assets %5.7-0.17.06.44.8 
Return on equity %3.2-24.69.09.94.1 
Return on capital %13.1-1.121.223.718.1 
Exports to sales %56.260.560.065.366.4 
Imports to sales %16.115.622.727.722.4 
Exports (fob) Rs m1,2661,0351,5041,8362,020 
Imports (cif) Rs m362266568779683 
Fx inflow Rs m1,2661,0351,5041,8362,020 
Fx outflow Rs m390292586796716 
Net fx Rs m8757429181,0401,305 
BAL PHARMA CASH FLOW
From Operations Rs m 78 232 223 268 -18 
From Investments Rs m -80 -47 -55 -95 -222 
From Financial Activity Rs m 0 -200 -166 -172 244 
Net Cashflow Rs m -3 -16 2 1 4 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.2%
Institution 0.1%
Non-Institution 48.6%
Total 100.0%
Free Float 48.8%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off #21&22 Bommasandra Industrial Area, Anekal Taluk, Bengaluru - 560099
E-mail investor@balpharma.com Web www.balpharma.com
Tel 080 41570811 / 13 / 19 Fax 080 41570820 / 22354057
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C-101 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli West
CHM: Shailesh Siroya COMP SEC: Abdul Basith YEAR OF INC: 1987 BSE CODE: 524824 FV (Rs): 10 DIV YIELD (%): 1.0

Read: BAL PHARMA 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUN PHARMA    CIPLA    

Compare BAL PHARMA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUN PHARMA    CIPLA    



 

Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.